ArticleDrug design, development and therapy2020

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells.

Zhenyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.